![credits @ceinge2024](/sites/default/files/styles/news_page/public/2024-02/%40CEINGE_%20MAVILIO%20F_22%2002%2024_ore%2012%2000.jpg?itok=ozZ1P6_n)
Hematopoietic stem cell gene therapy for sickle-cell disease
Fulvio Mavilio, Professor of Molecular Biology at the Department of Life Sciences of the University of Modena and Reggio Emilia, will hold a seminar at CEINGE entitled "Hematopoietic stem cell gene therapy for sickle-cell disease" (starting at 12.00).
Professor Mavilio is a member of the GENE-THERAPY PNRR-SPOKE 1 project. Furthermore, he is Chief Scientific Officer at Orchard Therapeutics (research and clinical development involving hematopoietic stem cell, or HSC, gene therapy).
Hosted by professors Achille Iolascon and Massimo Zollo.
* PER PARTECIPARE online:
https://us02web.zoom.us/j/86579927917?pwd=U0haMEQyUVYyTVYvTFppK3U3eWQxQT09
Meeting ID: 865 7992 7917
Passcode: 012952
LUOGO DELL'EVENTO
Auditorium CEINGE-Biotecnologie avanzate Franco Salvatore
- 80131
- Napoli
- NA
Allegati
FLYER3.59 MB